Veröffentlichungen | MDC Berlin

307 Ergebnisse:

Active Filter:

13. Januar 2021 in J Biol Chem

Pantoea stewartii WceF is a glycan biofilm modifying enzyme with a bacteriophage tailspike-like fold

T. Irmscher
Y. Roske
I. Gayk
V. Dunsing
S. Chiantia
U. Heinemann
S. Barbirz

11. Januar 2021 in EMBO J

Ythdf is a N6-methyladenosine reader that modulates Fmr1 target mRNA selection and restricts axonal growth in Drosophila

L. Worpenberg
C. Paolantoni
S. Longhi
M.M. Mulorz
T. Lence
H.H. Wessels
E. Dassi
G. Aiello
F.X.R. Sutandy
M. Scheibe
R.R. Edupuganti
A. Busch
M.M. Möckel
M. Vermeulen
F. Butter
J. König
M. Notarangelo
U. Ohler
C. Dieterich
A. Quattrone
A. Soldano
J.Y. Roignant

07. Januar 2021 in Cancers

Cold-shock domains - abundance, structure, properties, and nucleic-acid binding

U. Heinemann
Y. Roske

29. Dezember 2020 in Cell Rep

USP15 deubiquitinase safeguards hematopoiesis and genome integrity in hematopoietic stem cells and leukemia cells

P. van den Berk
C. Lancini
C. Company
M. Serresi
M.P. Sanchez-Bailon
D. Hulsman
C. Pritchard
J.Y. Song
M.J. Schmitt
E. Tanger
O. Popp
P. Mertins
I.J. Huijbers
H. Jacobs
M. van Lohuizen
G. Gargiulo
E. Citterio

23. Dezember 2020 in Cancer Discov

Phenotypic mapping of pathological crosstalk between glioblastoma and innate immune cells by synthetic genetic tracing

M.J. Schmitt
C. Company
Y. Dramaretska
I. Barozzi
A. Göhrig
S. Kertalli
M. Großmann
H. Naumann
M.P. Sanchez-Bailon
D. Hulsman
R. Glass
M. Squatrito
M. Serresi
G. Gargiulo

22. Dezember 2020 in Mol Cell

Protein synthesis in the developing neocortex at near-atomic resolution reveals Ebp1-mediated neuronal proteostasis at the 60S tunnel exit

M.L. Kraushar
F. Krupp
D. Harnett
P. Turko
M.C. Ambrozkiewicz
T. Sprink
K. Imami
M. Günnigmann
U. Zinnall
C.H. Vieira-Vieira
T. Schaub
A. Münster-Wandowski
J. Bürger
E. Borisova
H. Yamamoto
M.R. Rasin
U. Ohler
D. Beule
T. Mielke
V. Tarabykin
M. Landthaler
G. Kramer
I. Vida
M. Selbach
C.M.T. Spahn

17. Dezember 2020 in Blood

Tumor and microenvironment response but no cytotoxic T-cell activation in classic Hodgkin lymphoma treated with anti-PD1

S. Reinke
P.J. Bröckelmann
I. Iaccarino
M. Garcia-Marquez
S. Borchmann
F. Jochims
M. Kotrova
K. Pal
M. Brüggemann
E. Hartmann
S. Sasse
C. Kobe
S. Mathas
M. Soekler
U. Keller
M. Bormann
A. Zimmermann
J. Richter
M. Fuchs
B. von Tresckow
P. Borchmann
H. Schlößer
M. von Bergwelt-Baildon
A. Rosenwald
A. Engert
W. Klapper

10. Dezember 2020 in J Med Chem

From pyrazolones to azaindoles: evolution of active-site SHP2 inhibitors based on scaffold hopping and bioisosteric replacement

Y. Mostinski
G.J.J.E. Heynen
M.P. López-Alberca
J. Paul
S. Miksche
S. Radetzki
D. Schaller
E. Shanina
C. Seyffarth
Y. Kolomeets
N. Ziebart
J. de Schryver
S. Oestreich
M. Neuenschwander
Y. Roske
U. Heinemann
C. Rademacher
A. Volkamer
J.P. von Kries
W. Birchmeier
M. Nazaré

07. Dezember 2020 in Dev Cell

Lineage-resolved enhancer and promoter usage during a time course of embryogenesis

J.P. Reddington
D.A. Garfield
O.M. Sigalova
A. Karabacak Calviello
R. Marco-Ferreres
C. Girardot
R.R. Viales
J.F. Degner
U. Ohler
E.E.M. Furlong

24. November 2020 in Proc Natl Acad Sci U S A

Designed nanomolar small-molecule inhibitors of Ena/VASP EVH1 interaction impair invasion and extravasation of breast cancer cells

M. Barone
M. Müller
S. Chiha
J. Ren
D. Albat
A. Soicke
S. Dohmen
M. Klein
J. Bruns
M. van Dinther
R. Opitz
P. Lindemann
M. Beerbaum
K. Motzny
Y. Roske
P. Schmieder
R. Volkmer
M. Nazaré
U. Heinemann
H. Oschkinat
P. Ten Dijke
H.G. Schmalz
R. Kühne